Fecal Immunochemical Test (FIT) and Helicobacter pylori Stool Antigen Co-Testing for Gastric Cancer
Gastric cancer is a leading cause of cancer death globally. Chronic H pylori infection is the primary cause of gastric cancer, responsible for at least 80% of the new cases. Constanza Camargo, PhD, of the National Cancer Institute joins JAMA Associate Editor John M. Inadomi, MD, to discuss co-testing with FIT and H pylori stool antigen to help prevent gastric cancer.
Related Content:
Fecal Immunochemical Test and Helicobacter pylori Stool Antigen Co-Testing
Screening for Helicobacter pylori to Prevent Gastric Cancer
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.